Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
Journal of Virology|October 12, 2018
P2X Antagonists Inhibit HIV-1 Productive Infection and Inflammatory Cytokines Interleukin-10 (IL-10) and IL-1β in a Human Tonsil Explant ModelAlexandra Y Soare, Natasha D Durham, Ramya Gopal, et al.Journal of Virology|December 20, 2019
P2X1 Selective Antagonists Block HIV-1 Infection through Inhibition of Envelope Conformation-Dependent FusionAlexandra Y Soare, Hagerah S Malik, Natasha D Durham, et al.Journal of Virology|November 30, 2023
HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse modelAlice K Min, Behnam Javidfar, Roy Missall, et al.Antiviral Research|January 31, 2025
High HIV-1 viremia and low anti-Env antibody responses are associated with delayed treatment response to fostemsavir in highly treatment-experienced individualsSvenja Weiss, Raymond A Alvarez, Marisa Goff, et al.Biorxiv : the Preprint Server for Biology|May 10, 2023
HIV-1 infection of genetically engineered iPSC-derived central nervous system-engrafted microglia in a humanized mouse modelAlice K Min, Behnam Javidfar, Roy Missall, et al.Nature Communications|March 5, 2025
Tracking HIV persistence across T cell lineages during early ART-treated HIV-1-infection using a reservoir-marking humanized mouse modelNamita Satija, Foramben Patel, Gerrit Schmidt, et al.Molecular Cell|December 16, 2022
HIV integration in the human brain is linked to microglial activation and 3D genome remodelingAmara L Plaza-Jennings, Aditi Valada, Callan O'Shea, et al.Cell Reports|December 6, 2018
Cooperative Transcription Factor Induction Mediates Hemogenic ReprogrammingAndreia M Gomes, Ilia Kurochkin, Betty Chang, et al.Retrovirology|September 8, 2016
The HIV-1 late domain-2 S40A polymorphism in antiretroviral (or ART)-exposed individuals influences protease inhibitor susceptibilitySusan M Watanabe, Viviana Simon, Natasha D Durham, et al.JCI Insight|February 28, 2017
Enhanced FCGR2A and FCGR3A signaling by HIV viremic controller IgGRaymond A Alvarez, Ana M Maestre, Kenneth Law, et al.Pageof 6